Patient’s characteristics of control and DM-treated/untreated groups.

Figshare2020-01-07 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Patient_s_characteristics_of_control_and_DM-treated_untreated_groups_/11539758 数据链接链接失效反馈

官方服务：

资源简介：

Patient’s characteristics of control and DM-treated/untreated groups.

创建时间：

2020-01-07

Key demographic descriptors for all responding facilities (N = 38).

医疗人口统计

患者特征分组

ED = Emergency department. ICU = Intensive Care Unit. Neonates defined as 18 years.

NIAID Data Ecosystem40

Supplementary Material for: Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial

糖尿病临床试验

肾脏-心血管结局评估

Background: Among diabetics, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality, and progression of their underlying disease. Finerenone is a novel,

Figshare2019-10-25 更新10

Effects on various gluco-metabolic and lipid parameters of lobeglitazone as compared with placebo from baseline to 24 weeks.

糖尿病临床试验

糖脂代谢评估

HOMA-β, homeostasis model assessment of β-cell function; HOMA-IR, homeostasis model assessment of insulin resistance; HDL, high-density lipoprotein; LDL, low-density lipoprotein;* Outlier values are r

Figshare2015-12-02 更新10

MOESM4 of Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial

糖尿病临床试验

心力衰竭治疗

Additional file 4. Â Trial organization.

Figshare2016-12-15 更新30

Dataset from Effect of Semaglutide Once-weekly Versus Insulin Aspart Three Times Daily, Both as Add on to Metformin and Optimised Insulin Glargine (U100) in Subjects With Type 2 Diabetes A 52-week, Multi-centre, Multinational, Open-label, Active-controlled, Two Armed, Parallel-group, Randomised Trial in Subjects With Type 2 Diabetes

糖尿病临床试验

糖尿病药物疗效比较

This study will compare the effect of semaglutide once weekly to insulin aspart 3 times daily as add on to metformin and insulin glargine in people with type 2 diabetes. Participants will either get i

NIAID Data Ecosystem10

Patient’s characteristics of control and DM-treated/untreated groups.

资源简介：

相关数据集